Skip to main content
. Author manuscript; available in PMC: 2019 Aug 30.
Published in final edited form as: Br J Psychiatry. 2018 Feb 1;212(2):88–95. doi: 10.1192/bjp.2017.18

Table 3. Between-group differences from baseline to 6-month follow-up adjusted for baseline scores, age, sex, medication use and chronicity.

Outcome n Coefficient 95% CI P-value
PHQ-9 score 103 -3.64 (-6.06, -1.23) 0.004
GAD-7 score 99 -2.83 (-5.03, -0.64) 0.012
HADS depression score 97 -2.83 (-4.67, -0.99) 0.003
HADS anxiety score 97 -2.39 (-4.33, -0.45) 0.017
WSAS score 96 -5.31 (-9.35, -1.27) 0.011